Stella Diagnostics Inc. (SLDX)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -5.7 Million USD | -1.18% |
| 2022 | -5.64 Million USD | 66.1% |
| 2021 | -16.64 Million USD | -6250.04% |
| 2020 | -262.05 Thousand USD | 75.78% |
| 2019 | -1.08 Million USD | 40.03% |
| 2018 | -1.8 Million USD | -33392.72% |
| 2017 | -5386.00 USD | 0.0% |
| 2015 | -44.24 Thousand USD | 77.72% |
| 2014 | -198.57 Thousand USD | -76876.09% |
| 2013 | -257.97 USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -329.65 Thousand USD | -8.33% |
| 2024 Q1 | -304.3 Thousand USD | 81.23% |
| 2023 Q4 | -1.62 Million USD | -98.63% |
| 2023 FY | -5.7 Million USD | -1.18% |
| 2023 Q1 | -2.87 Million USD | -178.01% |
| 2023 Q2 | -390.36 Thousand USD | 86.44% |
| 2023 Q3 | -816.36 Thousand USD | -109.13% |
| 2022 Q2 | -110.94 Thousand USD | 97.19% |
| 2022 FY | -5.64 Million USD | 66.1% |
| 2022 Q4 | -1.03 Million USD | -41.5% |
| 2022 Q3 | -731.91 Thousand USD | -559.72% |
| 2022 Q1 | -3.94 Million USD | 0.0% |
| 2021 Q2 | -442.91 Thousand USD | 0.0% |
| 2021 Q3 | -195.4 Thousand USD | 55.88% |
| 2021 FY | -16.64 Million USD | -6250.04% |
| 2020 Q3 | -6.53 Million USD | -642.4% |
| 2020 FY | -262.05 Thousand USD | 75.78% |
| 2020 Q1 | -3089.00 USD | 0.0% |
| 2020 Q2 | -880.7 Thousand USD | -28410.84% |
| 2019 FY | -1.08 Million USD | 40.03% |
| 2018 FY | -1.8 Million USD | -33392.72% |
| 2018 Q1 | -220.26 Thousand USD | 0.0% |
| 2017 FY | -5386.00 USD | 0.0% |
| 2015 FY | -44.24 Thousand USD | 77.72% |
| 2014 FY | -198.57 Thousand USD | -76876.09% |
| 2013 FY | -257.97 USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | -304.782% |
| Arrayit Corporation | -3.31 Million USD | -72.139% |
| Atlantic International Corp. | -5.62 Million USD | -1.419% |
| Biocept, Inc. | -32.08 Million USD | 82.213% |
| Bioqual, Inc. | 483.48 Thousand USD | 1280.487% |
| CardioGenics Holdings Inc | -1.91 Million USD | -197.832% |
| DermTech, Inc. | -100.88 Million USD | 94.343% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 100.282% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 73.57% |
| iMD Companies, Inc. | -200.63 Thousand USD | -2744.668% |
| IDenta Corp. | 14.64 Thousand USD | 39074.515% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 811.649% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 14852.069% |
| InVitro International | 1553.00 USD | 367609.852% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | 33.573% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -9721.428% |
| Medical Imaging Corp. | -3.02 Million USD | -88.799% |
| NovelStem International Corp. | -4.18 Million USD | -36.303% |
| Optigenex Inc. | -2.89 Million USD | -96.96% |
| PharmChem, Inc. | 845.1 Thousand USD | 775.354% |
| Proteome Sciences plc | -2.44 Million USD | -133.624% |
| Response Genetics, Inc | -20.18 Million USD | 71.723% |
| Rennova Health, Inc. | -3.29 Million USD | -73.317% |
| RushNet, Inc. | -607.02 Thousand USD | -840.225% |
| ScreenPro Security Inc. | -2.24 Million USD | -153.803% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | 50.002% |
| Todos Medical Ltd. | -24.99 Million USD | 77.165% |